Boundless Bio Files 8-K: Agreement Termination & Financial Obligation
Ticker: BOLD · Form: 8-K · Filed: Apr 13, 2026
Sentiment: neutral
Topics: agreement-termination, financial-obligation
TL;DR
Boundless Bio terminated a key deal and took on new debt. Big changes ahead.
AI Summary
On April 13, 2026, Boundless Bio, Inc. filed an 8-K report detailing the termination of a material definitive agreement and the creation of a direct financial obligation. The specific details of the agreement and the financial obligation are not provided in this summary.
Why It Matters
This filing indicates significant changes in Boundless Bio's contractual and financial standing, which could impact its operations and future strategic decisions.
Risk Assessment
Risk Level: medium — The termination of a material definitive agreement and the creation of a new financial obligation suggest potential financial distress or a significant shift in business strategy, warranting a medium risk assessment.
Key Players & Entities
- Boundless Bio, Inc. (company) — Filer of the 8-K report
- 0001782303 (company) — CIK number for Boundless Bio, Inc.
- 2026-04-13 (date) — Filing date and period of report
FAQ
What was the material definitive agreement that Boundless Bio terminated?
The filing does not specify the details of the material definitive agreement that was terminated.
What is the nature of the direct financial obligation created by Boundless Bio?
The filing indicates the creation of a direct financial obligation but does not provide specific details about its nature or terms.
When was this 8-K filing submitted to the SEC?
The 8-K filing was submitted on April 13, 2026.
What are the CIK and EIN for Boundless Bio, Inc.?
The CIK for Boundless Bio, Inc. is 0001782303 and the EIN is 830751369.
What items are specifically mentioned in this 8-K filing?
This 8-K filing specifically mentions Item 1.02 (Termination of a Material Definitive Agreement) and Item 2.03 (Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 13, 2026 regarding Boundless Bio, Inc. (BOLD).